Neuro Institute of New England P C — Foxborough, Massachusetts

Neuro Institute of New England P C is a clinical research site located in Foxborough, Massachusetts, United States 02035.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

Neuro Institute of New England P C has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Multiple Sclerosis, Secondary Progressive Multiple Sclerosis (SPMS), Relapsing Multiple Sclerosis.

Sponsors: EMD Serono Research & Development Institute, Inc., Novartis Pharmaceuticals, Hoffmann-La Roche.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Foxborough

Browse all research sites in Massachusetts · View every site in Foxborough

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Neuro Institute of New England P C?

Neuro Institute of New England P C has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Neuro Institute of New England P C conducted?

Neuro Institute of New England P C has 3 clinical trials on record, with 2 currently active. Their work covers Multiple Sclerosis, Secondary Progressive Multiple Sclerosis (SPMS), Relapsing Multiple Sclerosis.

Is Neuro Institute of New England P C accredited by Crixeo Clinical Trials?

Neuro Institute of New England P C has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Neuro Institute of New England P C?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.